Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Effect of Letrozole on Breast Biomarkers of High Risk Postmenopausal Women Receiving Hormone Replacement Therapy

NCT00291135 is registered in ClinicalTrials.gov with Carol Fabian, MD as lead sponsor.

NCT NCT00291135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00291135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Effect of Letrozole on Breast Biomarkers of High Risk Postmenopausal Women Receiving Hormone Replacement Therapy
Lead sponsor
Carol Fabian, MD
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2003
Completion date
October 31, 2008
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer